Ali Agah is an experienced biotechnology entrepreneur and investor with a strong background in electrical engineering. They co-founded Avantome Inc., developing a low-cost DNA sequencing platform before its acquisition by Illumina. At Illumina, Ali served as Associate Director and Director of Research, leading multi-disciplinary teams to advance next-generation sequencing technologies. Currently, Ali is the co-founder and CEO of Cellanome, focusing on cross-disciplinary innovations at the intersection of biology and technology, and they are also involved in a spin-off, Cytoprism, as a strategic leader. Additionally, they hold the position of Managing Partner at Aban Capital, overseeing significant investments in early-stage life science startups. Ali earned a PhD in Electrical Engineering from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices